Exploring Metabolic Pathways and Regulation through Functional Chemoproteomic and Metabolomic Platforms  Daniel Medina-Cleghorn, Daniel K. Nomura  Chemistry.

Slides:



Advertisements
Similar presentations
Volume 14, Issue 2, Pages (August 2011)
Advertisements

Enzyme Annotation with Chemical Tools
New Light on Methylthiolation Reactions
Succinate: A New Epigenetic Hacker
Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
Accelerating drug discovery: Open source cancer cell biology?
Volume 21, Issue 7, Pages (July 2014)
Ready, Set, Cleave: Proteases in Action
Volume 18, Issue 7, Pages (July 2011)
Acetate Fuels the Cancer Engine
Volume 19, Issue 5, Pages (May 2012)
Using Epigenetic Reprogramming to Treat Pediatric Brain Cancer
ROS Function in Redox Signaling and Oxidative Stress
An Enzyme that Regulates Ether Lipid Signaling Pathways in Cancer Annotated by Multidimensional Profiling  Kyle P. Chiang, Sherry Niessen, Alan Saghatelian,
Chemical Proteomics of Host-Pathogen Interaction
Beyond genetics: epigenetic code in chronic kidney disease
IDH1, Histone Methylation, and So Forth
Jacqueline L. Blankman, Gabriel M. Simon, Benjamin F. Cravatt 
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Patrick S. Ward, Craig B. Thompson  Cancer Cell 
Mapping Proteome-wide Targets of Glyphosate in Mice
Nitzan Koppel, Emily P. Balskus  Cell Chemical Biology 
Understanding the Intersections between Metabolism and Cancer Biology
Metabolomics and Metabolic Diseases: Where Do We Stand?
Volume 22, Issue 7, Pages (July 2015)
Maxime Janin, Manel Esteller  Cell Metabolism 
IKKɛ: A Bridge between Obesity and Inflammation
Volume 23, Issue 5, Pages (May 2016)
Volume 24, Issue 11, Pages e4 (November 2017)
How Chemoproteomics Can Enable Drug Discovery and Development
Volume 1, Issue 6, Pages (June 2012)
Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes  Jessica P.
Activity-Based Profiling for Drug Discovery
Microbes, Microbiota, and Colon Cancer
Targeting Bacterial Central Metabolism for Drug Development
Cancer’s Fuel Choice: New Flavors for a Picky Eater
Silencing Insulin Resistance through SIRT1
Cancer’s Fuel Choice: New Flavors for a Picky Eater
Lung Cancer Resets the Liver’s Metabolic Clock
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Volume 22, Issue 10, Pages (October 2015)
Connecting Threads: Epigenetics and Metabolism
A Ceramide-Centric View of Insulin Resistance
Glycomics Hits the Big Time
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism  Jonathan Z. Long, Daniel.
Jae Won Chang, Daniel K. Nomura, Benjamin F. Cravatt 
Volume 22, Issue 7, Pages (July 2015)
Richard W. Gross, Xianlin Han  Chemistry & Biology 
Fueling Up Skeletal Muscle to Reduce Obesity: A TrkB Story
Volume 17, Issue 8, Pages (August 2010)
Daniel I. Benjamin, Benjamin F. Cravatt, Daniel K. Nomura 
Xinxin Gao, Rami N. Hannoush  Cell Chemical Biology 
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Volume 14, Issue 2, Pages (August 2011)
Harnessing the Antioxidant Power with ARE-Inducing Compounds
Cancer and Inflammation: An Aspirin a Day Keeps the Cancer at Bay
Volume 18, Issue 1, Pages (January 2011)
Volume 21, Issue 9, Pages (September 2014)
Anthony T. Phan, Ananda W. Goldrath, Christopher K. Glass  Immunity 
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Tools to Tackle Protein Acetylation
Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes  Jessica P.
Methylglyoxal Comes of AGE
Tenets of PTEN Tumor Suppression
Volume 18, Issue 3, Pages (January 2017)
Volume 21, Issue 9, Pages (September 2014)
Ready, Set, Cleave: Proteases in Action
A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress  Benjamin Guy Trist, Dominic.
Presentation transcript:

Exploring Metabolic Pathways and Regulation through Functional Chemoproteomic and Metabolomic Platforms  Daniel Medina-Cleghorn, Daniel K. Nomura  Chemistry & Biology  Volume 21, Issue 9, Pages 1171-1184 (September 2014) DOI: 10.1016/j.chembiol.2014.07.007 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Activity-Based Protein Profiling (A) Examples of activity-based probes. (B) Gel-based ABPP and ABPP-MudPIT platforms for fluorescent and mass-spectrometry-based analysis of enzyme activities. Rh, rhodamine; B, biotin. Chemistry & Biology 2014 21, 1171-1184DOI: (10.1016/j.chembiol.2014.07.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Competitive ABPP Platforms (A) ABPP-SILAC. (B) Fluopol-ABPP. (C) Isotope-ABPP. Chemistry & Biology 2014 21, 1171-1184DOI: (10.1016/j.chembiol.2014.07.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 Targeted and Untargeted Metabolomic Profiling Platforms Targeted metabolomic approaches oftentimes are performed by multiple reaction monitoring-based liquid chromatography-tandem mass spectrometry methods. Untargeted metabolomic approaches are performed through collecting all mass spectra and using bioinformatics tools (e.g., XCMS) to identify, integrate, and compare ions among comparison groups. Chemistry & Biology 2014 21, 1171-1184DOI: (10.1016/j.chembiol.2014.07.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 4 Examples of Metabolic Pathways Elucidated by Metabolomic Profiling (A) ABHD12 was characterized as a LPS hydrolase. ABHD12 deficiency leads to an accumulation in LPS, activates toll-like receptor 2, induces neuroinflammation, and causes a neurodegenerative disease known as PHARC (retinitis pigmentosa, hearing loss, ataxia, cataract, and polyneuropathy). (B) MAGL was shown to play critical roles of controlling endocannabinoid and eicosanoid signaling in the brain and fatty acid and fatty acid-derived oncogenic signaling lipids in cancer. MAGL blockade in the brain leads to elevations in 2-AG endocannabinoid signaling and anxiolytic and antinociceptive effects, while also lowering the primary arachidonic acid precursor pool for pro-inflammatory eicosanoid production, leading to reduced inflammation, and neuroprotection against neurodegenerative diseases. In cancer, MAGL blockade leads to reduced fatty acids and fatty acid-derived signaling lipids such as prostaglandins and lysophosphatidic acid, which impairs cancer pathogenicity. (C) In cancer, AGPS was shown to not only control ether lipid synthesis, but also fatty acid metabolism that balances structural lipids with signaling lipids that fuel cancer. AGPS knockdown in cancer cells leads to reductions in the tumor-promoting lipid lysophosphatidic acid-ether, leading to a diversion of arachidonic acid away from oncogenic prostaglandins and toward structural lipids, leading to a net impairement in cancer aggressiveness. Chemistry & Biology 2014 21, 1171-1184DOI: (10.1016/j.chembiol.2014.07.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 5 Examples of Posttranslational Modifications Regulated by Specific Metabolites (A) isoTOP-ABPP was used to map distinct hyperreactive cysteines that were particularly sensitive to modification by the endogenously produced reactive electrophile 4-hydroxy-2-nonenal. (B) Posttranslational regulation by a glycolytic product 1,3-bisphosphoglycerate that modifies lysines on glycolytic enzymes and inhibits their activity. Chemistry & Biology 2014 21, 1171-1184DOI: (10.1016/j.chembiol.2014.07.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 6 Metabolic Control of Epigenetic Features (A) Mutant IDH1 R132H generates 2-HG, inhibiting histone demethylases to fuel cancer progression through multiple mechanisms. (B) ACL activity controls acetyl-CoA levels to confer nutrient-responsive histone acetylation and gene expression, altering glucose metabolism and cellular programming of macromolecular synthesis and energy production. (C) Increased expression of NNMT in cancer decreases histone methylation, increasing expression of tumor-promoting genes. In white adipose tissue, inactivation of NNMT increases polyamine synthesis and histone methylation, elevating gene expression and activity of enzymes critical for high energy expenditure. Chemistry & Biology 2014 21, 1171-1184DOI: (10.1016/j.chembiol.2014.07.007) Copyright © 2014 Elsevier Ltd Terms and Conditions